| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/15/2003 | US6548739 Method for activating peroxisome proliferator activated receptor-γ |
| 04/15/2003 | US6548736 Transgenic mouse with modified 7B2 gene having a phenotype of at least one of hypoglycemia, hyperproinsulinemia, hypercortisolism, increased plasma ACTH (adrenocorticotrophin) or increased serum corticosterone |
| 04/15/2003 | US6548735 5'-flanking sequence such as beta-lactoglobulin and DNA coding for a serine protease such as alpha1-antitrypsin or a blood factor |
| 04/15/2003 | US6548656 Single-stranded DNA with a palindrome base sequence that are able to prepare DNA sequences having correct translation frames before and behind the any cleaved sites |
| 04/15/2003 | US6548655 Interleukin-4 receptors |
| 04/15/2003 | US6548654 DNA encoding mammalian CX3C chemokine genes |
| 04/15/2003 | US6548653 Erythropoietin analog-human serum albumin fusion |
| 04/15/2003 | US6548652 Attachment of oligonucleotides to solid supports through schiff base type linkages for capture and detection of nucleic acids |
| 04/15/2003 | US6548651 Modified peptide nucleic acid (PNA) molecules |
| 04/15/2003 | US6548650 Nucleic acid encoding melanoma differentiation associated gene-9 |
| 04/15/2003 | US6548642 Expression of synthetic genes designed from repetitive peptide sequences of hydroxyproline-rich glycoproteins |
| 04/15/2003 | US6548641 PTP 1D: a novel protein tyrosine phosphatase |
| 04/15/2003 | US6548634 Peptidic composition linked to an oligomerization domain directly or through a linker or heparin binding domain; no homology to naturally occuring fibroblast growth factors (fgf) |
| 04/15/2003 | US6548633 Complementary DNA's encoding proteins with signal peptides |
| 04/15/2003 | US6548632 Fusions of scaffold proteins with random peptide libraries |
| 04/15/2003 | US6548631 Macrophage derived chemokine (MDC) as an anti-viral agent for the treatment and prevention of lentivirus infection |
| 04/15/2003 | US6548607 High density, miniaturized arrays and methods of manufacturing same |
| 04/15/2003 | US6548475 Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuronal and neural injury |
| 04/15/2003 | US6548306 Placental protein 13 |
| 04/15/2003 | US6548302 Polymers for delivery of nucleic acids |
| 04/15/2003 | US6548301 Expression vectors having a reduced content of viral genes, are safer because of expressing more nonviral nucleotide and much less immunogenic or toxic proteins; contain less than 400 bp of the nucleotide sequwence which codes for gag |
| 04/15/2003 | US6548298 Transcriptional unit complementary to human telomerase RNA sequence linked to regulating sequences |
| 04/15/2003 | US6548296 Methods for identifying human cell lines useful for endogenous gene activation, isolated human lines identified thereby, and uses thereof |
| 04/15/2003 | US6548292 From Pseudomonas; comprises genes encoding enzymes involved in catchol cleavage, mercury tolerance, plasmid stability, and replication |
| 04/15/2003 | US6548291 Polynucleotide sequences/transgenic cells of Bacillus thuringiensis |
| 04/15/2003 | US6548290 Geminin gene and protein |
| 04/15/2003 | US6548289 Integrating into a symbiotically silent region of Rhizobium meliloti DNA encoding for inositol dehydrogenase (IDH), a cassette comprising transcriptional promoter gene |
| 04/15/2003 | US6548287 Non-pyrogenic bacterial strains and use of the same |
| 04/15/2003 | US6548286 Methods for increasing the efficiency of recombinant AAV product |
| 04/15/2003 | US6548285 Polynucleotides encoding Aspergillus Niger and Penicillium Chrysogenum acetamidases and methods of use as selectable markers |
| 04/15/2003 | US6548284 Membrane-bound metalloprotease and soluble secreted form thereof |
| 04/15/2003 | US6548282 Enzymatic polypeptide for use in nutrients of animal feeds |
| 04/15/2003 | US6548281 Polypeptides, polynucleotides formed via recombination; for screening for antibacterial compounds |
| 04/15/2003 | US6548280 Genes encoding sulfate assimilation proteins |
| 04/15/2003 | US6548277 Method for molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase |
| 04/15/2003 | US6548274 Methods for producing a polypeptide using a crippled translational initiator sequence |
| 04/15/2003 | US6548272 Pathogenic gene for bipolar affective disorder |
| 04/15/2003 | US6548271 Introducing into a cell an expression vector containing nucleic acid molecule operatively associated with regulatory nucleic acid controlling expression of nucleic acid molecule in the cell; culturing the cell to produce polypeptide |
| 04/15/2003 | US6548270 An expression vector comprising a recombinant polynucleotide encoding a protein containing specific amino acid sequence; genetic engineering |
| 04/15/2003 | US6548267 Motor proteins and methods for their use |
| 04/15/2003 | US6548262 Hemostasis system-related disorders treatment |
| 04/15/2003 | US6548257 Monitoring preferential expression; provide a pool of target ribonucleic acid sequences, hybridize to immobilized probes, measure nucleic acid hybridization to soild support |
| 04/15/2003 | US6548256 Isolating nucleotide sequences from sample; obtain sample inoculate with bacteria, precipate nucleotide sequences with ethanol and detergent, incubate nucleotide sequence sample with membrane, release the nucleic acid from the membrane |
| 04/15/2003 | US6548255 Immobilization |
| 04/15/2003 | US6548253 Method of isolating plasmid DNA |
| 04/15/2003 | US6548250 Methods for detection of a target nucleic acid sequence |
| 04/15/2003 | US6548249 Fusions of scaffold proteins with random peptide libraries |
| 04/15/2003 | US6548246 Method and probes for the identification of microbial genes specifically induced during host infection |
| 04/15/2003 | US6548244 Process for typing HCV isolates |
| 04/15/2003 | US6548070 Attenuated strains of mycobacteria |
| 04/15/2003 | US6548068 Genetic engineered vaccine; gene coding antigen to disease and genetic engineerded viruses inserted into genome |
| 04/15/2003 | US6548067 Antigenic constructs of major histocompatibility complex class I antigens with specific carrier molecules, the preparation and use thereof |
| 04/15/2003 | US6548063 Synferon |
| 04/15/2003 | US6548060 Anti-apoptotic use of human glutaminyl-tRNA synthetase with two consecutive pro-apoptotic mediators |
| 04/15/2003 | US6547769 Catheter apparatus with weeping tip and method of use |
| 04/15/2003 | CA2403258A1 Three dimensional crystal structure of human sorbitol dehydrogenase and uses thereof |
| 04/15/2003 | CA2348665C Root-preferred promoters and their use |
| 04/15/2003 | CA2257101C Dna sequences encoding phytases of ruminal microorganisms |
| 04/15/2003 | CA2245594C Bioluminescent novelty items |
| 04/15/2003 | CA2034504C Fungal stress proteins |
| 04/15/2003 | CA2026280C Biotin-labelled dna by polymerase chain reaction and detection thereof |
| 04/12/2003 | CA2403827A1 Compositions and methods for genetic analysis of polycystic kidney disease |
| 04/11/2003 | WO2002031131A1 Novel pla1 |
| 04/11/2003 | WO2002030961A1 Novel peptides |
| 04/11/2003 | CA2425845A1 Novel pla1 |
| 04/11/2003 | CA2425769A1 Novel peptides |
| 04/10/2003 | WO2003029924A2 Adaptive baseline algorithm for quantitative pcr |
| 04/10/2003 | WO2003029824A1 Method and agent for diagnosing and treating chronic inflammatory bowel diseases |
| 04/10/2003 | WO2003029821A1 Target assisted iterative screening (tais) : a novel screening format for large molecular repertoires |
| 04/10/2003 | WO2003029492A1 Metabolic genes and related methods and compositions |
| 04/10/2003 | WO2003029489A1 Methods for detection of target molecules and molecular interactions |
| 04/10/2003 | WO2003029486A2 Single nucleotide polymorphisms predicting cardiovascular disease |
| 04/10/2003 | WO2003029485A2 Specific differential display arrays |
| 04/10/2003 | WO2003029484A2 Antimicrobial methods and materials |
| 04/10/2003 | WO2003029476A2 Process for the preparation of d-pantothenic acid and/or its salts |
| 04/10/2003 | WO2003029475A1 MAMMALIAN CELL-INFECTING VIRUS VECTOR ENCODING EPITOPE-BOUND β2m AND UTILIZATION THEREOF |
| 04/10/2003 | WO2003029474A1 Method of regulating expression of gene carried on viral vector |
| 04/10/2003 | WO2003029473A1 Genetic tagging strategy for inducing and identifying mutations in a genomic sequence |
| 04/10/2003 | WO2003029472A1 A method for directional expression cloning with zero background and high throughput |
| 04/10/2003 | WO2003029471A1 Muteins of apolipoprotein d |
| 04/10/2003 | WO2003029470A1 PROCESS FOR PRODUCING α1,4-GALACTOSYLTRANSFERASE AND GALACTOSE-CONTAINING COMPLEX SUGAR |
| 04/10/2003 | WO2003029469A1 Novel selenocystein-containing proteins |
| 04/10/2003 | WO2003029468A1 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 04/10/2003 | WO2003029467A1 Candidate protein for novel cell polarization factor and polynucleotide encoding the protein |
| 04/10/2003 | WO2003029466A1 Sodium-independent transporter transporting small-sized neutral amino acid, gene thereof and method of analyzing transporter function by constructing fused proteins enabling the specification of the function |
| 04/10/2003 | WO2003029465A1 HepNaDC GENE |
| 04/10/2003 | WO2003029464A2 Genes associated with mast cell activation |
| 04/10/2003 | WO2003029463A2 Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| 04/10/2003 | WO2003029462A1 Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| 04/10/2003 | WO2003029461A1 A method of genetic screening using an amplifiable gene |
| 04/10/2003 | WO2003029460A1 Polynucleotide fragments of an infectious human endogenous retrovirus |
| 04/10/2003 | WO2003029459A2 Micro-rna molecules |
| 04/10/2003 | WO2003029458A2 Method for producing protein libraries and for selecting proteins from said libraries |
| 04/10/2003 | WO2003029456A1 Multi-chain eukaryotic display vectors and uses thereof |
| 04/10/2003 | WO2003029455A1 Nucleic acid extracting device |
| 04/10/2003 | WO2003029454A2 Non-human animal model for analysis of the origin and therapy of organ fibrosis |
| 04/10/2003 | WO2003029453A2 Induction of gene expression by silencing of repressor genes |
| 04/10/2003 | WO2003029451A2 Histone deacetylase 9 |
| 04/10/2003 | WO2003029448A1 Recombinant adenovirus with enhanced therapeutic effect and pharmaceutical composition comprising said recombinant adenovirus |
| 04/10/2003 | WO2003029442A1 Method for production of recombinant proteins in eukaryote cells |